Loading clinical trials...
Loading clinical trials...
Exercise Performance on Ambient Air vs. Commonly Prescribed Nasal Low Oxygen Therapy - a Non-Inferiority Trial in Patients With Exercise Induced Desaturation Due to Chronic Lung Diseases
The investigators aim to study the effect of SOT in subjects with chronic lung disease in submaximal exercise.
Participants with lung disease who live in Switzerland will have 6-minute walk distance (6MWD) test with and without SOT at approximately 3l/min via nasal cannula according to a randomized cross-over design. The trial aims to test that the 6MWD with SOT is non-inferior to a 6MWD in the same participant under ambient air. Our effect size was estimated with a difference of less or equal to 35m compared under SOT compared to ambient air.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
University Hospital Zürich
Zurich, Canton of Zurich, Switzerland
Start Date
May 1, 2024
Primary Completion Date
July 1, 2025
Completion Date
July 1, 2025
Last Updated
December 10, 2025
40
ACTUAL participants
6-minute walk distance (6MWD) test on ambient air
OTHER
6-minute walk distance test with supplemental oxygen (approximately 3l/min, nasal)
OTHER
Lead Sponsor
University of Zurich
NCT04707781
NCT06122233
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT05722340